MedTrace Logo

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery

NCT06467409 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-06-21

No results posted yet for this study

Summary

A randomized, double-blind, placebo/positive drug parallel controlled design was used to evaluate the preliminary efficacy and safety of intravenous infusion of LPM3480392 injection using different dosing regimens in subjects with moderate to severe pain after Orthopedic surgery

Conditions

  • Pain, Postoperative

Interventions

DRUG

Placebo

patient-controlled analgesia(PCA) administration

DRUG

morphine hydrochloride injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

DRUG

LPM3480392 Injection

patient-controlled analgesia(PCA) administration

Sponsors & Collaborators

  • Luye Pharma Group Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-26
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06467409 on ClinicalTrials.gov